Estresse associado a transformação de língua geográfica de passiva para ativa durante a pandemia da Covid-19: relato de caso
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Jul 30, 2022
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Reportar um caso de língua geográfica passiva que se tornou ativa devido à presença de forte estresse relacionado à pandemia da doença do coronavírus 2019 (COVID-19). Detalhamento de Caso: Em janeiro de 2019, uma participante de pesquisa do gênero feminino, caucasiana, de 42 anos de idade foi incluída em um estudo sobre língua geográfica (LG). Na ocasião, embora ela relatasse ser portadora da condição, ao exame intraoral, não foram observadas áreas atróficas ou margens esbranquiçadas em sua língua (sinais clínicos clássicos de LG). Em novembro de 2020 a mesma foi novamente contatada e relatou alterações em sua LG. Na presente data, as bordas laterais de sua língua apresentavam áreas eritematosas circundadas por margens esbranquiçadas. A participante de pesquisa também relatou que se encontrava sob forte estresse devido à pandemia. Considerações finais: Este relato de caso demonstrou consistência com os dados da literatura quanto ao aparecimento, piora dos sintomas e alterações nos aspectos clínicos da lingua geográfica associados a fatores emocionais e psicológicos. Para assegurar que as mudanças nos aspectos clínicos da LG podem estar relacionadas ao estresse pandêmico, pesquisas adicionais sobre as manifestações orais de COVID-19 são necessárias.
##plugins.themes.bootstrap3.article.details##
Como Citar
SarrufM. B. J. M., SarrufG. J. M., OliveiraH. E., QuinelatoH., AguiarT. R. da S., Calasans-MaiaJ. de A., CasadoP. L., CavalcanteL. M. A., & QuinelatoV. (2022). Estresse associado a transformação de língua geográfica de passiva para ativa durante a pandemia da Covid-19: relato de caso. Revista Eletrônica Acervo Saúde, 15(7), e10686. https://doi.org/10.25248/reas.e10686.2022
Seção
Estudos de Caso
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. ALIKHANI M, et al. Immunologic and psychologic parameters associated with geographic tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 118: 68-71.
2. ANSARI M, et al. Dynamic assessment of economic and environmental performance index and generation, composition, environmental and human health risks of hospital solid waste in developing countries; A state of the art of review. Environment International, 2019; 132: 105073.
3. BERNAOLA PAREDES WE, et al. A case of migratory stomatitis in a young male patient: Management and differential diagnosis. J Oral Maxillofac Pathol., 2022; 26: S17-21.
4. CAMPANA F, et al. Geographic stomatitis with palate involvement. An Bras Dermatol. 2019; 94(4): 449-51.
5. CAMPBELL CM, KAHWASH R. Will complement inhibition be the new target in treating COVID-19–related systemic thrombosis? Circulation. 2020; 141(22): 1739–41.
6. CAMPOS WG, et al. Treatment of symptomatic benign migratory glossitis: a systematic review. Clin Oral Investig. 2018; 22(7): 2487-2493.
7. CARRERAS-PRESAS CM, et al. Oral vesiculobullous lesions associated with Sars-Cov-2 infection. Oral Diseases. 2020; 00: 1–3.
8. CHEN N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13.
9. CHEVANCE A, et al. Ensuring mental health care during the Sars-Cov-2 epidemic in France: A narrative review. L’Encéphale. 2020; 46: 193–201.
10. DU Y, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Critic Care Med. 2020; 201(11): 1372–9.
11. ESTÉBANEZ A, et al. Cutaneous manifestations in COVID‐19: a new contribution. Journal of the European Academy of Dermatology and Venereology. 2020; 34(6): e250-e251.
12. GONZAGA HF, et al. Environmental factors in benign migratory glossitis and psoriasis: retrospective study of the association of emotional stress and alcohol and tobacco consumption with benign migratory glossitis and cutaneous psoriasis. J Eur Acad, Dermatol.Venereol. 2015; 29: 533-6.
13. GONZÁLEZ-ÁLVAREZ L, et al. Lengua geográfica: factores predisponentes, diagnóstico y tratamiento. Revisión sistemática. Rev Clin Esp. 2018; 218(9): 481-488.
14. GOSWAMI M, et al. Benign migratory glossitis with fissured tongue. J Indian Soc Pedod Prev Dent. 2012; 30(2): 173-175
15. GUO YR, et al. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research. 2020; 7(1): 1-10.
16. JERNIGAN DB. Update: Public health response to the coronavirus disease 2019 outbreak. — United States, February 24, 2020. Morb Mortal Wkly Report. 2020; 69(8): 216-219.
17. KAUR D, et al. Oral manifestations of stress-related disorders in the general population of Ludhiana. J Indian Acad Oral Med Radiol. 2016; 28: 262-269.
18. LUI DTW, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021; 106: e926–e935.
19. MAGLIOCCA KR, FITZPATRICK SG. Autoimmune disease manifestations in the oral cavity. Surg Pathol Clin. 2017; 10: 57-88.
20. MALLAH SI, et al. COVID‑19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 2021;20(35):1-36.
21. MANGOLD AR, et al. Diseases of the tongue. Clin Dermatol. 2016; 34: 458-69.8
22. OGUETA IC, et al. Geographic Tongue: What a Dermatologist Should Know. Actas Dermosifiliogr. 2019; 110(5): 341-346.
23. PICCIANI BLS, et al. Geographic tongue severity index: A new and clinical scoring system. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 129(4): 330‐338.
24. PINNA R, et al. Genetic and developmental disorders of the oral mucosa: Epidemiology; molecular mechanisms; diagnostic criteria; management. Periodontol 2000. 2019; 80: 12–27.
25. PRASANTH VJ. Geographic Tongue. CMAJ. 2021; 13(193): E1424.
26. PREM K, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020; 5(5): e261-e270
27. QIU J, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. Gen. Psychiatry. 2020; 33: e100213.
28. SANTOS JA, et al. Oral mucosal lesions in a COVID‐19 patient: new signs or secondary manifestations? Int J Infect Dis. 2020; 97: 326‐ 328.
29. SCALA A, et al. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275 91.
30. SCARIOT R, et al. Host and clinical aspects in patients with benign migratory glossitis. Arch OralBiol. 2017; 73: 259-68.
31. SEAH I, AGRAWAL R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28(3): 391–5.
32. TANG N, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–7.
33. TOSCANO G, et al. Guillain- Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382: 2574–2576.
34. TO K K-W, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerging Microbes & Infections. 2021; 10: 507-535.
35. VINDEGAARD N, BENROS ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020, 89: 531–542.
36. XU H, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int JOral Sci. 2020; 12(1): 8.
37. XU L, et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40(5): 998–1004.
38. WORLD HEALTH ORGANIZATION (WHO). WHO announces COVID-19 outbreak a pandemic. Geneva: World Health Organization; 2020.
2. ANSARI M, et al. Dynamic assessment of economic and environmental performance index and generation, composition, environmental and human health risks of hospital solid waste in developing countries; A state of the art of review. Environment International, 2019; 132: 105073.
3. BERNAOLA PAREDES WE, et al. A case of migratory stomatitis in a young male patient: Management and differential diagnosis. J Oral Maxillofac Pathol., 2022; 26: S17-21.
4. CAMPANA F, et al. Geographic stomatitis with palate involvement. An Bras Dermatol. 2019; 94(4): 449-51.
5. CAMPBELL CM, KAHWASH R. Will complement inhibition be the new target in treating COVID-19–related systemic thrombosis? Circulation. 2020; 141(22): 1739–41.
6. CAMPOS WG, et al. Treatment of symptomatic benign migratory glossitis: a systematic review. Clin Oral Investig. 2018; 22(7): 2487-2493.
7. CARRERAS-PRESAS CM, et al. Oral vesiculobullous lesions associated with Sars-Cov-2 infection. Oral Diseases. 2020; 00: 1–3.
8. CHEN N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13.
9. CHEVANCE A, et al. Ensuring mental health care during the Sars-Cov-2 epidemic in France: A narrative review. L’Encéphale. 2020; 46: 193–201.
10. DU Y, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Critic Care Med. 2020; 201(11): 1372–9.
11. ESTÉBANEZ A, et al. Cutaneous manifestations in COVID‐19: a new contribution. Journal of the European Academy of Dermatology and Venereology. 2020; 34(6): e250-e251.
12. GONZAGA HF, et al. Environmental factors in benign migratory glossitis and psoriasis: retrospective study of the association of emotional stress and alcohol and tobacco consumption with benign migratory glossitis and cutaneous psoriasis. J Eur Acad, Dermatol.Venereol. 2015; 29: 533-6.
13. GONZÁLEZ-ÁLVAREZ L, et al. Lengua geográfica: factores predisponentes, diagnóstico y tratamiento. Revisión sistemática. Rev Clin Esp. 2018; 218(9): 481-488.
14. GOSWAMI M, et al. Benign migratory glossitis with fissured tongue. J Indian Soc Pedod Prev Dent. 2012; 30(2): 173-175
15. GUO YR, et al. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research. 2020; 7(1): 1-10.
16. JERNIGAN DB. Update: Public health response to the coronavirus disease 2019 outbreak. — United States, February 24, 2020. Morb Mortal Wkly Report. 2020; 69(8): 216-219.
17. KAUR D, et al. Oral manifestations of stress-related disorders in the general population of Ludhiana. J Indian Acad Oral Med Radiol. 2016; 28: 262-269.
18. LUI DTW, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021; 106: e926–e935.
19. MAGLIOCCA KR, FITZPATRICK SG. Autoimmune disease manifestations in the oral cavity. Surg Pathol Clin. 2017; 10: 57-88.
20. MALLAH SI, et al. COVID‑19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 2021;20(35):1-36.
21. MANGOLD AR, et al. Diseases of the tongue. Clin Dermatol. 2016; 34: 458-69.8
22. OGUETA IC, et al. Geographic Tongue: What a Dermatologist Should Know. Actas Dermosifiliogr. 2019; 110(5): 341-346.
23. PICCIANI BLS, et al. Geographic tongue severity index: A new and clinical scoring system. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 129(4): 330‐338.
24. PINNA R, et al. Genetic and developmental disorders of the oral mucosa: Epidemiology; molecular mechanisms; diagnostic criteria; management. Periodontol 2000. 2019; 80: 12–27.
25. PRASANTH VJ. Geographic Tongue. CMAJ. 2021; 13(193): E1424.
26. PREM K, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020; 5(5): e261-e270
27. QIU J, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. Gen. Psychiatry. 2020; 33: e100213.
28. SANTOS JA, et al. Oral mucosal lesions in a COVID‐19 patient: new signs or secondary manifestations? Int J Infect Dis. 2020; 97: 326‐ 328.
29. SCALA A, et al. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275 91.
30. SCARIOT R, et al. Host and clinical aspects in patients with benign migratory glossitis. Arch OralBiol. 2017; 73: 259-68.
31. SEAH I, AGRAWAL R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28(3): 391–5.
32. TANG N, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–7.
33. TOSCANO G, et al. Guillain- Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382: 2574–2576.
34. TO K K-W, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerging Microbes & Infections. 2021; 10: 507-535.
35. VINDEGAARD N, BENROS ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020, 89: 531–542.
36. XU H, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int JOral Sci. 2020; 12(1): 8.
37. XU L, et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40(5): 998–1004.
38. WORLD HEALTH ORGANIZATION (WHO). WHO announces COVID-19 outbreak a pandemic. Geneva: World Health Organization; 2020.